Search

Lexicon Pharmaceuticals Inc

Închisă

SectorSănătate

2 1.52

Rezumat

Modificarea prețului

24h

Curent

Minim

1.9300000000000002

Maxim

2

Indicatori cheie

By Trading Economics

Venit

-32M

-33M

Vânzări

-20M

692K

EPS

-0.06

Marjă de profit

-4,742.486

Angajați

81

EBITDA

-30M

-29M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+151.67% upside

Dividende

By Acuity

Următoarele câștiguri

5 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-38M

997M

Deschiderea anterioară

0.48

Închiderea anterioară

2

Sentimentul știrilor

By Acuity

34%

66%

67 / 339 Clasament în Healthcare

Lexicon Pharmaceuticals Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

11 sept. 2026, 20:08 UTC

Lexicon Pharmaceuticals Inc. shares are lower today, continuing a decline since Thursday's close. Earlier, the stock peaked before reversing course during routine fluctuations.

10 sept. 2026, 19:21 UTC

News

Lexicon Pharmaceuticals is lower today, continuing a five-session decline amid broader market pressures following the European Central Bank's interest rate hike.

8 sept. 2026, 20:07 UTC

Lexicon Pharmaceuticals shares are lower today, following a strong jobs report that raised interest rate hike speculation. The stock remains below its 20-day moving average.

5 sept. 2026, 00:00 UTC

Lexicon Pharmaceuticals Inc shares are higher in after-market trading, reflecting gains since Friday's close amid broader market dynamics and strong labor market data.

3 sept. 2026, 19:26 UTC

Lexicon Pharmaceuticals Inc is higher today, with no specific news identified. Broader market declines in Treasury yields may be influencing trading.

24 aug. 2026, 19:36 UTC

News

Lexicon Pharmaceuticals received a $10 million milestone payment from Novo Nordisk, bringing total payments to $75 million as shares rise during Monday's session.

21 aug. 2026, 19:36 UTC

Lexicon Pharmaceuticals Inc shares are higher in Friday's session, continuing an upward trend since Thursday. The stock remains below its 20-day moving average.

20 aug. 2026, 23:56 UTC

Lexicon Pharmaceuticals Inc shares are rising in after-market trading, showing positive momentum despite being below their 20-day moving average. No specific news was identified.

18 aug. 2026, 19:31 UTC

Lexicon Pharmaceuticals Inc shares are higher today, driven by significant gains in the Biotechnology sub-sector. The stock is near its one-month high.

13 aug. 2026, 19:56 UTC

Lexicon Pharmaceuticals is trading lower today amid no specific news. First-time claims for U.S. unemployment benefits rose, but investor sentiment remains stable.

12 aug. 2026, 23:36 UTC

Lexicon Pharmaceuticals Inc's shares are higher in after-market trading, with no specific news identified. Broader market sentiment may be influenced by recent inflation data.

11 aug. 2026, 23:26 UTC

Lexicon Pharmaceuticals Inc. shares are lower in after-market trading, with no specific news identified. Broader market sentiment remains cautious amid oil price developments.

10 aug. 2026, 19:56 UTC

News

Lexicon Pharmaceuticals reported a second-quarter earnings loss of -$0.06 per share, missing expectations. Shares are lower amid a downgrade to “sell” from Wall Street Zen.

7 aug. 2026, 22:01 UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market hours, continuing a notable decline since Friday's close, with no specific news identified to explain the movement.

6 aug. 2026, 23:26 UTC

Lexicon Pharmaceuticals shares are trading higher in after-market hours, following three consecutive sessions of declines. No specific news was identified for the price movement.

5 aug. 2026, 19:36 UTC

News

Lexicon Pharmaceuticals Inc shares are lower as investors adjust positions ahead of Q2 earnings on August 5, with consensus EPS estimates at -$0.05.

4 aug. 2026, 19:56 UTC

Lexicon Pharmaceuticals shares are higher today, reflecting strong momentum amid easing inflation concerns from declining crude oil prices. No specific news was identified.

31 iul. 2026, 19:46 UTC

Lexicon Pharmaceuticals Inc shares are lower today, reflecting broader market trends amid rising yields and crude oil prices contributing to inflation concerns.

30 iul. 2026, 23:11 UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market hours. The decline follows broader market uncertainty after the Federal Reserve's interest rate decision.

29 iul. 2026, 21:02 UTC

Lexicon Pharmaceuticals Inc shares are lower in after-market trading, reflecting broader market declines amid rising oil prices and geopolitical tensions in the Middle East.

27 iul. 2026, 19:03 UTC

Lexicon Pharmaceuticals Inc is trading lower today, breaking a trend of higher daily closes. Broader market declines and falling oil prices may influence sentiment.

24 iul. 2026, 20:07 UTC

Lexicon Pharmaceuticals Inc shares are lower today, reversing from earlier gains amid broader market volatility influenced by falling oil prices and inflation concerns.

22 iul. 2026, 19:02 UTC

Lexicon Pharmaceuticals Inc shares are lower today, continuing a decline since Tuesday's close. The stock remains below its 20-day moving average.

21 iul. 2026, 19:42 UTC

Lexicon Pharmaceuticals is higher as the market gains momentum, driven by strong performances from major companies and a resurgence in semiconductor stocks.

20 iul. 2026, 19:06 UTC

Lexicon Pharmaceuticals Inc shares are lower today, following three days of gains. Broader market declines are linked to rising US Treasury yields and oil prices above $90.

Comparație

Modificare preț

Lexicon Pharmaceuticals Inc Așteptări

Obiectiv de preț

By TipRanks

151.67% sus

Prognoză pe 12 luni

Medie 5.033 USD  151.67%

Maxim 6 USD

Minim 3.1 USD

În baza a 3 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruLexicon Pharmaceuticals Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

3 ratings

3

Cumpărare

0

Păstrare

0

Vânzare

Sentiment

By Acuity

67 / 339 Clasament în Sănătate

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.
help-icon Live chat